Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katie Welldon

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Audiology|October 4, 2018
The Effect of Increased Cognitive Demand on Auditory Processing AssessmentKathryn Hamlyn, Katie Welldon, Benjamin Clark, et al.
Biomaterials|January 27, 2004
The proliferation and phenotypic expression of human osteoblasts on tantalum metalDavid M Findlay, Katie Welldon, Gerald J Atkins, et al.
Thrombosis and Haemostasis|March 28, 2002
A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentratesEmmanuel J Favaloro, Melinda Bukuya, Teresa Martinelli, et al.
Cancer Research|May 19, 2006
Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse modelLe Minh Thai, Agatha Labrinidis, Shelley Hay, et al.
International Journal of Cancer|March 22, 2006
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAILLisa M Butler, Vasilios Liapis, Stelios Bouralexis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Audiology|October 4, 2018
The Effect of Increased Cognitive Demand on Auditory Processing AssessmentKathryn Hamlyn, Katie Welldon, Benjamin Clark, et al.
Biomaterials|January 27, 2004
The proliferation and phenotypic expression of human osteoblasts on tantalum metalDavid M Findlay, Katie Welldon, Gerald J Atkins, et al.
Thrombosis and Haemostasis|March 28, 2002
A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentratesEmmanuel J Favaloro, Melinda Bukuya, Teresa Martinelli, et al.
Cancer Research|May 19, 2006
Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse modelLe Minh Thai, Agatha Labrinidis, Shelley Hay, et al.
International Journal of Cancer|March 22, 2006
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAILLisa M Butler, Vasilios Liapis, Stelios Bouralexis, et al.
Pageof 1